The combined use of cytosine arabinoside, cyclophosphamide, and total body irradiation as preparative regimen for bone marrow transplantation in patients with AML and CML

Autor: H A, Messner, J E, Curtis, M M, Minden

Publikováno v: Seminars in oncology. 12(2 Suppl 3)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f6d75e1d5cdd48af71da558d63b6e7cf
https://pubmed.ncbi.nlm.nih.gov/3892701

Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis.

Autor: Zioni N; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Bercovich AA; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel., Chapal-Ilani N; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Bacharach T; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Rappoport N; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.; Blavatnik School of Computer Science, Tel Aviv University, Tel Aviv, Israel., Solomon A; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel., Avraham R; Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel., Kopitman E; Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Porat Z; Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Sacma M; Institute of Molecular Medicine Ulm University, Ulm, Germany., Hartmut G; Institute of Molecular Medicine Ulm University, Ulm, Germany., Scheller M; Department of Medicine, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany., Muller-Tidow C; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Heidelberg, Heidelberg, Germany., Lipka D; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Heidelberg, Heidelberg, Germany., Shlush E; IVF Unit, Galilee Medical Center, Nahariya, Israel., Minden M; Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada.; Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada.; Division of Hematology, University Health Network, Toronto, ON, Canada., Kaushansky N; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Shlush LI; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. liran.shlush@weizmann.ac.il.; Hematology and Bone Marrow Transplantation Institute Rambam Healthcare campus Haifa, Haifa, Israel. liran.shlush@weizmann.ac.il.

Publikováno v: Nature communications [Nat Commun] 2023 Apr 12; Vol. 14 (1), pp. 2070. Date of Electronic Publication: 2023 Apr 12.

Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: a Canadian consensus.

Autor: Couban S; Department of Medicine, Dalhousie University, Halifax, NS., Savoie L; University of Calgary, Calgary, AB., Mourad YA; Leukemia and Bone Marrow Transplant Program of British Columbia, University of British Columbia, Vancouver, BC., Leber B; McMaster University, Hamilton, ON., Minden M; Department of Medical Oncology, University Health Network, University of Toronto, Toronto, ON., Turner R; Cross Cancer Institute, Edmonton, AB., Palada V; University of Toronto, St Michael's Hospital, Toronto, ON., Shehata N; University of Toronto, St Michael's Hospital, Toronto, ON., Christofides A; Senior Medical Writer, Toronto, ON., Lachance S; Hospital Maisonneuve-Rosemont, University of Montreal, Montreal, QC.

Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2014 Apr; Vol. 21 (2), pp. e265-309.

Elevated calpain activity in acute myelogenous leukemia correlates with decreased calpastatin expression.

Autor: Niapour M, Farr C, Minden M, Berger SA

Publikováno v: Blood cancer journal [Blood Cancer J] 2012 Jan; Vol. 2 (1), pp. e51. Date of Electronic Publication: 2012 Jan 13.

Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies.

Autor: Siegal D; Blood and Marrow Transplant Program, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada., Xu W, Sutherland R, Kamel-Reid S, Kuruvilla J, Lipton JH, Minden M, Messner H, Gupta V

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2008 Jul; Vol. 42 (1), pp. 51-6. Date of Electronic Publication: 2008 Mar 31.